Shane Storey
Stock Analyst at Canaccord Genuity
(1.43)
# 3,704
Out of 5,134 analysts
355
Total ratings
43.2%
Success rate
-0.2%
Average return
Main Sectors:
Stocks Rated by Shane Storey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: TLX Telix Pharmaceuticals Limited | Reiterated: Buy | $31.50 | $13.44 | +134.38% | 60 | Nov 8, 2026 | |
| ASX: IDX Integral Diagnostics Limited | Downgraded: Hold | $2.57 → $1.77 | $1.65 | +7.27% | 13 | Nov 2, 2026 | |
| ASX: RMD ResMed Inc. | Downgraded: Hold | $40.00 → $35.61 | $35.28 | +0.94% | 23 | Nov 1, 2026 | |
| ASX: CSL CSL Limited | Reiterated: Hold | $185.00 | $202.22 | -8.52% | 30 | Oct 1, 2026 | |
| ASX: ACW Actinogen Medical Limited | Reiterated: Buy | $0.08 | $0.05 | +77.78% | 6 | Sep 3, 2026 | |
| ASX: SOM SomnoMed Limited | Reiterated: Buy | $1.00 → $0.76 | $0.31 | +145.16% | 23 | Aug 31, 2026 | |
| ASX: PNV PolyNovo Limited | Downgraded: Hold | $1.58 → $0.95 | $0.89 | +6.50% | 17 | Aug 27, 2026 | |
| NZE: FPH Fisher & Paykel Healthcare Corporation Limited | Reiterated: Buy | $45.97 → $44.74 | $48.43 | -7.62% | 16 | May 27, 2026 | |
| ASX: ARX Aroa Biosurgery Limited | Reiterated: Buy | $1.16 → $1.35 | $0.49 | +175.51% | 28 | May 3, 2026 | |
| ASX: COH Cochlear Limited | Reiterated: Buy | $295.00 → $120.00 | $150.86 | -20.46% | 19 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $0.69 → $0.86 | $0.76 | +13.91% | 20 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.33 → $1.26 | $0.56 | +125.00% | 2 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5.43 → $5.55 | $2.93 | +89.42% | 21 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3.85 → $2.40 | $3.37 | -28.68% | 3 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.07 → $0.06 | $0.00 | +1,400.00% | 22 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $350.00 | $200.85 | +74.26% | 5 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.85 → $0.80 | $0.27 | n/a | 4 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $37.00 | $54.78 | n/a | 11 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32.84 | $7.59 | n/a | 3 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.00 → $2.81 | $0.16 | n/a | 4 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.20 | $0.02 | n/a | 2 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.00 | $1.79 | n/a | 3 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26.50 | $22.95 | n/a | 1 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8.50 | $1.82 | n/a | 7 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.00 | $0.01 | n/a | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5.95 → $7.40 | $3.22 | n/a | 2 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $0.71 → $0.55 | $0.46 | n/a | 3 | Feb 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $0.17 → $0.06 | $0.65 | n/a | 2 | Sep 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $0.50 → $0.55 | $0.07 | n/a | 3 | Aug 29, 2022 |
Telix Pharmaceuticals Limited
Nov 8, 2026
Reiterated: Buy
Price Target: $31.50
Current: $13.44
Upside: +134.38%
Integral Diagnostics Limited
Nov 2, 2026
Downgraded: Hold
Price Target: $2.57 → $1.77
Current: $1.65
Upside: +7.27%
ResMed Inc.
Nov 1, 2026
Downgraded: Hold
Price Target: $40.00 → $35.61
Current: $35.28
Upside: +0.94%
CSL Limited
Oct 1, 2026
Reiterated: Hold
Price Target: $185.00
Current: $202.22
Upside: -8.52%
Actinogen Medical Limited
Sep 3, 2026
Reiterated: Buy
Price Target: $0.08
Current: $0.05
Upside: +77.78%
SomnoMed Limited
Aug 31, 2026
Reiterated: Buy
Price Target: $1.00 → $0.76
Current: $0.31
Upside: +145.16%
PolyNovo Limited
Aug 27, 2026
Downgraded: Hold
Price Target: $1.58 → $0.95
Current: $0.89
Upside: +6.50%
Fisher & Paykel Healthcare Corporation Limited
May 27, 2026
Reiterated: Buy
Price Target: $45.97 → $44.74
Current: $48.43
Upside: -7.62%
Aroa Biosurgery Limited
May 3, 2026
Reiterated: Buy
Price Target: $1.16 → $1.35
Current: $0.49
Upside: +175.51%
Cochlear Limited
Apr 29, 2026
Reiterated: Buy
Price Target: $295.00 → $120.00
Current: $150.86
Upside: -20.46%
Apr 29, 2026
Reiterated: Hold
Price Target: $0.69 → $0.86
Current: $0.76
Upside: +13.91%
Apr 20, 2026
Reiterated: Buy
Price Target: $1.33 → $1.26
Current: $0.56
Upside: +125.00%
Mar 4, 2026
Reiterated: Buy
Price Target: $5.43 → $5.55
Current: $2.93
Upside: +89.42%
Feb 17, 2026
Downgraded: Hold
Price Target: $3.85 → $2.40
Current: $3.37
Upside: -28.68%
Feb 2, 2026
Reiterated: Buy
Price Target: $0.07 → $0.06
Current: $0.00
Upside: +1,400.00%
Nov 18, 2025
Reiterated: Buy
Price Target: $350.00
Current: $200.85
Upside: +74.26%
Nov 7, 2025
Reiterated: Buy
Price Target: $0.85 → $0.80
Current: $0.27
Upside: n/a
Oct 3, 2025
Reiterated: Hold
Price Target: $37.00
Current: $54.78
Upside: n/a
Sep 24, 2025
Reiterated: Buy
Price Target: $32.84
Current: $7.59
Upside: n/a
Sep 11, 2025
Reiterated: Buy
Price Target: $3.00 → $2.81
Current: $0.16
Upside: n/a
Sep 10, 2025
Reiterated: Buy
Price Target: $1.20
Current: $0.02
Upside: n/a
Sep 2, 2025
Reiterated: Buy
Price Target: $3.00
Current: $1.79
Upside: n/a
Aug 28, 2025
Reiterated: Buy
Price Target: $26.50
Current: $22.95
Upside: n/a
Aug 8, 2025
Reiterated: Buy
Price Target: $8.50
Current: $1.82
Upside: n/a
Mar 24, 2025
Reiterated: Hold
Price Target: $1.00
Current: $0.01
Upside: n/a
Feb 27, 2025
Downgraded: Hold
Price Target: $5.95 → $7.40
Current: $3.22
Upside: n/a
Feb 21, 2023
Reiterated: Hold
Price Target: $0.71 → $0.55
Current: $0.46
Upside: n/a
Sep 2, 2022
Downgraded: Hold
Price Target: $0.17 → $0.06
Current: $0.65
Upside: n/a
Aug 29, 2022
Reiterated: Hold
Price Target: $0.50 → $0.55
Current: $0.07
Upside: n/a